SecSonar.com

Align Technology, Inc. (ALGN)

Align Technology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Align Technology, Inc. (ALGN) is a Medical - Devices company based in US with a market capitalization of $12.6B. Revenue grew 0.9% year-over-year and the company generated $490.8M in free cash flow. This page tracks ALGN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 21.2K employees · IPO Jan 30, 2001

Valuation

Valuation & price

$157.25 · as of May 17, 2026 · -24.1% vs 52w high

27.8

P/E ratio

Latest-FY diluted EPS

3.12

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$206$166$125Jul 25Dec 25Jul 26Jul 7, 25$193.83Jul 9, 25$200.48Jul 11, 25$202.28Jul 15, 25$192.81Jul 17, 25$192.27Jul 21, 25$189.02Jul 23, 25$204.13Jul 25, 25$205.56Jul 29, 25$205.81Jul 31, 25$129.01Aug 4, 25$137.77Aug 6, 25$136.90Aug 11, 25$134.82Aug 13, 25$145.74Aug 15, 25$142.43Aug 19, 25$143.77Aug 21, 25$140.67Aug 25, 25$144.96Aug 27, 25$141.98Aug 29, 25$141.96Sep 3, 25$132.35Sep 5, 25$139.12Sep 9, 25$135.93Sep 11, 25$135.91Sep 16, 25$131.82Sep 18, 25$132.57Sep 22, 25$131.18Sep 24, 25$128.18Sep 26, 25$126.19Sep 30, 25$125.22Oct 2, 25$128.70Oct 6, 25$131.50Oct 8, 25$133.09Oct 10, 25$125.79Oct 14, 25$129.79Oct 16, 25$129.84Oct 21, 25$136.22Oct 23, 25$136.00Oct 27, 25$135.65Oct 29, 25$131.91Oct 31, 25$137.88Nov 4, 25$135.67Nov 6, 25$133.73Nov 10, 25$138.23Nov 12, 25$141.69Nov 14, 25$137.13Nov 18, 25$132.28Nov 20, 25$132.81Nov 25, 25$147.50Nov 28, 25$147.19Dec 2, 25$150.93Dec 4, 25$156.84Dec 8, 25$157.68Dec 10, 25$164.58Dec 12, 25$165.43Dec 16, 25$162.89Dec 18, 25$161.44Dec 22, 25$159.28Dec 24, 25$157.84Dec 29, 25$157.84Jan 2, 26$156.03Jan 6, 26$167.66Jan 8, 26$170.58Jan 12, 26$172.00Jan 14, 26$169.23Jan 16, 26$171.49Jan 21, 26$169.95Jan 23, 26$168.73Jan 27, 26$167.04Jan 29, 26$164.12Feb 2, 26$163.63Feb 4, 26$161.30Feb 9, 26$192.50Feb 11, 26$197.51Feb 13, 26$186.77Feb 18, 26$190.82Feb 20, 26$190.02Feb 24, 26$185.53Feb 26, 26$189.20Mar 2, 26$189.02Mar 4, 26$182.16Mar 6, 26$174.00Mar 10, 26$169.43Mar 12, 26$166.92Mar 17, 26$176.12Mar 19, 26$176.25Mar 23, 26$180.86Mar 25, 26$180.27Mar 27, 26$166.38Mar 31, 26$171.43Apr 2, 26$170.60Apr 7, 26$166.87Apr 9, 26$174.53Apr 13, 26$180.67Apr 15, 26$186.53Apr 17, 26$190.07Apr 22, 26$196.05Apr 24, 26$189.61Apr 28, 26$177.28Apr 30, 26$176.01May 4, 26$171.88May 6, 26$173.94May 8, 26$168.78May 12, 26$165.79May 14, 26$160.53May 18, 26$158.78May 20, 26$163.38May 22, 26$163.61May 28, 26$173.25Jun 1, 26$169.77Jun 3, 26$161.71Jun 5, 26$167.74Jun 9, 26$178.10Jun 11, 26$176.51Jun 15, 26$178.26Jun 17, 26$173.53Jun 22, 26$173.76Jun 24, 26$170.90Jun 26, 26$178.43Jul 2, 26$184.52
$124.8852-week range$207.19
Loading valuation history…

Fundamentals

Key fundamentals

$12.6B

Market cap

0.9%

Revenue growth (YoY)

68.3%

Gross margin

$490.8M

Free cash flow (USD)

-$980.5M

Net debt

Net cash position

-3.1%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.1BFY 2017$1.5BFY 2018$2.0BFY 2019$2.4BFY 2020$2.5BFY 2021$4.0BFY 2022$3.7BFY 2023$3.9BFY 2024$4.0BFY 2025$4.0B
$1.1B$4B

Free cash flow by year

2016 → 2025

FY 2016$177.1MFY 2017$242.8MFY 2018$331.4MFY 2019$597.6MFY 2020$507.3MFY 2021$771.4MFY 2022$276.8MFY 2023$608.1MFY 2024$622.7MFY 2025$490.8M
$177.1M$490.8M

Gross margin by year

2021 → 2025

FY 202174.3%FY 202270.5%FY 202370.1%FY 202470.0%FY 202568.3%
74.3%68.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard Leadership TransitionJun 22, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 20, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventShare RepurchaseMay 1, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing

Questions

Frequently asked questions

What is Align Technology, Inc.'s market cap?

Align Technology, Inc. (ALGN) has a market capitalization of $12.6B.

What is ALGN's P/E ratio?

ALGN trades at a price-to-earnings ratio of 27.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ALGN's price-to-book (P/B) ratio?

ALGN trades at 3.12 times book value per share.

Are insiders buying ALGN stock?

SEC Form 4 filings show no open-market insider buys at Align Technology, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

SNN

Smith & Nephew plc

$12.7B

PEN

Penumbra, Inc.

$12.5B

GMED

Globus Medical, Inc.

$11.1B

PODD

Insulet Corporation

$9.9B

MASI

Masimo Corporation

$9.3B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.